← Company intelligence

Robot maker · early

Cellular Origins

Corporate marketlabmedicalCurated record

TTP Group spin-out building Constellation, a robotic automation platform for scalable cell and gene therapy manufacturing: mobile robots plus automated sterile welding connect existing third-party bioprocess instruments, so therapies scale from clinical to commercial manufacture without redevelopment. Collaborating with Johnson & Johnson on an end-to-end automated platform for autologous CAR-T therapies, with integration partnerships with Cytiva and Thermo Fisher Scientific.

HeadquartersCambridge, GB
Founded2022
Corporate funding$40M
Team51-200
Deployments0
Open roles18
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageSeries A ($40M, J&J Innovation - JJDC lead)
FoundersEdwin Stone (CEO)
Regions servedEurope, North America
Countries deployedNot listed
Service footprintNot listed
Last reviewed2026-07-05
MX

Robot models

Specifications remain vendor-claimed

Machinelab

Constellation

  • Robotic ecosystem uniting mobile robotics and automated sterile welding with proven bioprocess instruments, giving cell-therapy makers a scalable route from clinical to commercial manufacture without therapy redevelopment

    vendor-stated robotic cell-therapy manufacturing capability

    Claim source
CA

Funding history

Publicly announced rounds

Investors on recordJohnson & Johnson Innovation - JJDCHighland EuropeBGFNYBC VenturesTTP Group
HR

Hiring signal

Public job board · 2026-07-13

Open roles18

Hiring is an operating signal, not deployment evidence. Roles are refreshed from the company’s public careers system.

TL

Company timeline

Milestones and announcements

2025-12-10Closed $40M over-subscribed Series A led by Johnson & Johnson Innovation - JJDC with Highland Europe, BGF, NYBC Ventures and TTPCellular Origins
2025-12-10Collaboration with Johnson & Johnson to develop scalable end-to-end automated manufacturing for autologous CAR-T cell therapies; Cytiva and Thermo Fisher Scientific integration partnershipsContract Pharma
SC

Source ledger

3 unique public sources